BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 19933193)

  • 1. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.
    Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of Transplanting Human Umbilical Cord Mesenchymal Stem Cells in a Microbead Induced Ocular Hypertension Rat Model.
    Ji S; Lin S; Chen J; Huang X; Wei CC; Li Z; Tang S
    Curr Eye Res; 2018 Jun; 43(6):810-820. PubMed ID: 29505314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes.
    Harper MM; Grozdanic SD; Blits B; Kuehn MH; Zamzow D; Buss JE; Kardon RH; Sakaguchi DS
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4506-15. PubMed ID: 21498611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model.
    Emre E; Yüksel N; Duruksu G; Pirhan D; Subaşi C; Erman G; Karaöz E
    Cytotherapy; 2015 May; 17(5):543-59. PubMed ID: 25618560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.
    Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma.
    Bull ND; Irvine KA; Franklin RJ; Martin KR
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4244-53. PubMed ID: 19357352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
    Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Valenta D; Baumrind LA; Pease ME
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):402-10. PubMed ID: 11818384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.
    Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA
    Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma.
    Mead B; Amaral J; Tomarev S
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):702-714. PubMed ID: 29392316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
    Ebneter A; Chidlow G; Wood JP; Casson RJ
    Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.
    Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
    Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.
    Roubeix C; Godefroy D; Mias C; Sapienza A; Riancho L; Degardin J; Fradot V; Ivkovic I; Picaud S; Sennlaub F; Denoyer A; Rostene W; Sahel JA; Parsadaniantz SM; Brignole-Baudouin F; Baudouin C
    Stem Cell Res Ther; 2015 Sep; 6(1):177. PubMed ID: 26377305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.
    Johnson TV; DeKorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI
    Brain; 2014 Feb; 137(Pt 2):503-19. PubMed ID: 24176979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury.
    Mead B; Logan A; Berry M; Leadbeater W; Scheven BA
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7544-56. PubMed ID: 24150755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
    Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
    Mammone T; Chidlow G; Casson RJ; Wood JPM
    Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension.
    Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR
    Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.